HEPAiRx Results Presented at International Conferences

Technical papers about HEPAiRx's effectiveness in improving asthma-related symptoms and the quality of life for children with asthma were presented by AI research partners from Clarkson University at the European Aerosol conference in Greece and the Indoor Air conference in Denmark in August.

The HEPAiRx™is an integrated energy recovery ventilator air purifier and an air conditioning unit designed to control temperature in the room while ventilating the room with approximately three air changes per hour of fresh outside air. The outside air is mixed with room air and then re-circulated through a HEPA filter approximately twelve times per hour.

The HEPAiRx proved to be effective for reducing particle and gas concentrations and for controlling the temperature in participants' bedrooms. The most notable improvements were in reduced particulate matter (PM) concentrations. Significantly lower exhaled breath (EBC) concentrations and high peak expiratory flow (PEF) rates point to improvement of the children's asthma symptoms during the day and night with the use of the HEPAiRx in their bedrooms.

Posters prepared for these conferences detail the study's experimental methods and protocols: "Investigation of the Effect of Indoor Particles on Lung Inflammation in Asthmatic Children" and "Air Cleaner Effects on Indoor Air Quality and Asthmatic Children's Health".

Carbon dioxide and volatile organic compounds before and after
HEPAiRx installation at a representative home

Temperature and relative humidity and particle concentrations
before and after HEPAiRx installation at a representative home